Immunic reported 400K in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 104M 136M Jun/2025
Dynavax Technologies USD 1.64M 2K Sep/2025
Enanta Pharmaceuticals USD 1.96M 620K Dec/2024
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 400K 400K Dec/2024
Insmed USD 20.38M 863K Sep/2025
Omeros USD 4.05M 5.16M Sep/2024
OraSure Technologies 2.91M 130K Dec/2024
Quidel USD 5.68B 5.63B Sep/2025
Ultragenyx Pharmaceutical USD 14.15M 108K Sep/2025
United Therapeutics USD 3M 4.3M Sep/2025
Xoma USD 3.4M 150K Jun/2024